Work

Phase I study of farnesyl tranferase inhibitors (FTI) SCH66336 with paclitaxel in solid tumors: Dose finding, pharmacokinetics, efficacy/safety

FWCI: 0.965
Cites:
Cited by: 11
Related to: 10